Intimation under Reg. 30 of SEBI (LODR) for entering into exclusive Purchase/Sale Agreement by our subsidiary.

Date: 29.09.2026 To, To, Lis(cid:415)ng Department Lis(cid:415)ng Department Na(cid:415)onal Stock Exchange of India Limited BSE Limited (“BSE”) (“NSE”) Department of Corporate Services Exchange Plaza, C-1 Block G, Bandra Kurla Phiroze Jeejeebhoy Towers, Complex Bandra [E], Mumbai – 400051 Dalal Street, Fort, Mumbai - 400 001 NSE Scrip Symbol: PLATIND BSE Scrip Code: 544134 ISIN: INE0PT501018 ISIN: INE0PT501018 Subject: In(cid:415)ma(cid:415)on regarding Exclusive Sale/Purchase Agreement entered into by our Subsidiary – Rivadu Lifesciences Private Limited Dear Sir / Madam, Pursuant to Regula(cid:415)on 30 of the SEBI (Lis(cid:415)ng Obliga(cid:415)ons and Disclosure Requirements) Regula(cid:415)ons, 2015, we wish to inform you that Rivadu Lifesciences Private Limited (“Rivadu”), a subsidiary of Pla(cid:415)num Industries Limited, has entered into an exclusive Sale/Purchase Agreement for India on 28th September 2026, with CAREGEN Co., Ltd., Korea (“CAREGEN”) in rela(cid:415)on to Caregen’s health func(cid:415)onal food finished products marketed under the brand name “Korglu(cid:415)de”. The relevant details as required under Regula(cid:415)on 30 read with Schedule III of the SEBI Lis(cid:415)ng Regula(cid:415)ons are enclosed as Annexure A. The above informa(cid:415)on shall be made available on the website of the Company at www.pla(cid:415)numindustriesltd.com. Kindly take the above in(cid:415)ma(cid:415)on on your record and oblige. Thanking You, Yours Faithfully, For Pla(cid:415)num Industries Limited Bhagyashree Mallawat Company Secretary and Compliance Officer M. No.: A51488 PLATINUM INDUSTRIES LIMITED CIN: L24299MH2020PLC341637 201, Ackru(cid:415) Star, Pocket No. 5, Central Road, MIDC, Marol, Andheri East, Mumbai-400069, Maharashtra. Tel.: 022-69983999 / 022-69983900 | E-mail: compliance@pla(cid:415)numindustriesltd.com Annexure A Disclosure of informa(cid:415)on pursuant to Regula(cid:415)on 30 of SEBI (LODR) Regula(cid:415)ons, 2015, read with Circular SEBI/HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026. Sr. No. Par(cid:415)cular Details Name of the en(cid:415)ty entering into the Rivadu Lifesciences Private Limited, agreement Subsidiary of Pla(cid:415)num Industries Limited 1 Name of the en(cid:415)ty with whom agreement is CAREGEN Co., Ltd., Korea entered 2 Purpose of entering into the agreement Exclusive Sale/Purchase Agreement for India in rela(cid:415)on to Korglu(cid:415)de. 3 shareholding, if any, in the en(cid:415)ty with whom NA the agreement is executed; 4 significant terms of the agreement (in brief) - Exclusive Partnership for Indian special rights like right to appoint directors, Territory. first right to share subscrip(cid:415)on in case of - Prospects for establishing manufacturing in India. issuance of shares, right to restrict any change in capital structure etc.; 5 whether, the said par(cid:415)es are related to No, the en(cid:415)ty with whom Agreement is promoter/promoter group/ group companies executed is not related. in any manner. If yes, nature of rela(cid:415)onship 6 whether the transac(cid:415)on would fall within No related party transac(cid:415)ons? If yes, whether the same is done at “arm’s length” 7 in case of issuance of shares to the par(cid:415)es, NA details of issue price, class of shares issued; 8 any other disclosures related to such NA agreements, viz., details of nominee on the board of directors of the listed en(cid:415)ty, poten(cid:415)al conflict of interest arising out of such agreements, etc.; 9 In case of termina(cid:415)on or amendment of NA agreement, listed en(cid:415)ty shall disclose addi(cid:415)onal details to the stock exchange(s): a) name of par(cid:415)es to the agreement; b) nature of the agreement; c) date of execu(cid:415)on of the agreement; d) details of amendment and impact thereof or reasons of termina(cid:415)on and impact thereof. PLATINUM INDUSTRIES LIMITED CIN: L24299MH2020PLC341637 201, Ackru(cid:415) Star, Pocket No. 5, Central Road, MIDC, Marol, Andheri East, Mumbai-400069, Maharashtra. Tel.: 022-69983999 / 022-69983900 | E-mail: compliance@pla(cid:415)numindustriesltd.com